SecBot SecBot
Insider Cluster (2 insiders) ·Filed Mar 6, 2026

LYEL

Lyell Immunopharma, Inc.
BULLISH
Impact 8/10
Horizonweeks Processed8mo ago
Insider cluster: 2 insiders, $25.0M total
Actionable Insight ▲ Bullish

This level of coordinated buying by a sophisticated biotech investor like ARCH Venture Partners is highly unusual and suggests strong conviction ahead of potential clinical or strategic developments. Traders should watch for upcoming catalysts such as trial readouts, partnerships, or funding news.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$22.46
T+0 close · Mar 5, 2026 · via day close
Latest settled
−23.64%
T+60 · $17.15
Vs SPY
−36.42%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 6 $22.46entry
  2. T+1 · 8mo ago +13.54%α +12.69% · $25.50
  3. T+5 · 8mo ago −5.39%α −3.86% · $21.25
  4. T+20 · 8mo ago −3.43%α −1.38% · $21.69
  5. T+60 · 6mo ago −23.64%α −36.42% · $17.15
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two funds affiliated with ARCH Venture Partners collectively purchased nearly $25 million worth of Lyell Immunopharma shares in open-market transactions at $25.61 per share. This represents a significant, coordinated investment by a major biotech venture firm, signaling strong confidence in the company's future prospects.

Key Financial Metrics

Direction
buying
Total Value
$25.0M
Insiders
2

Key Facts

  • ARCH Venture Partners IX, LLC purchased 488,090 shares at $25.61 for $12,500,000
  • ARCH Venture Fund XIII, L.P. purchased 488,090 shares at $25.61 for $12,500,000
  • Total open-market purchases: $25.0M across two affiliated funds
  • Transactions occurred on 2026-03-06 in a single day
  • Combined purchase represents approximately 5.2% of Lyell's $477M market cap

Financial Impact

$25.0 million in insider buying, equivalent to 5.2% of market capitalization

market sentimentshare ownershipinvestor confidence

Risk Factors

  • The purchases were made by affiliated funds, not company insiders (executives or directors), so this reflects investor confidence rather than direct management sentiment
  • Biotech stocks are inherently volatile and sensitive to clinical trial outcomes

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (2 trades, 7d window)cluster-LYEL-1773088624224

Track record

21 reports on LYEL

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +17.99% at T+60 after the Jun 8, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago S-3 Neutral 3/10 Entry $14.30 Now $14.65 +2.45% settles Nov 17
  2. Nov 12, 20264d ago Insider Cluster Bullish 6/10 Entry $14.30 to $14.65 Now $14.65 +2.45% ▲ +2.45% +4.36% vs SPY
  3. Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $16.86 to $15.64 Now $14.65 −13.11% ▼ −7.24% −6.88% vs SPY
  4. Nov 5, 202611d ago Insider Cluster Bullish 7/10 Entry $14.86 to $15.42 Now $14.65 −1.41% ▲ +3.77% +1.40% vs SPY
  5. Nov 4, 202612d ago 8-K Neutral 4/10 No price data
  6. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $15.00 to $14.86 Now $14.65 −2.33% ▼ −0.93% −1.25% vs SPY
  7. Nov 4, 202612d ago 8-K Bearish 5/10 Entry $15.43 to $15.00 Now $14.65 +5.06% ▲ +2.79% −1.62% vs SPY
  8. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $15.43 to $15.00 Now $14.65 −5.06% ▼ −2.79% +1.62% vs SPY
  9. Aug 25, 202611w ago Insider Cluster Neutral 4/10 Entry $14.80 to $14.61 Now $14.65 −1.01% ▼ −1.28% −1.94% vs SPY
  10. Jul 22, 202616w ago EFFECT Neutral 4/10 Entry $12.84 to $12.78 Now $14.65 +14.10% ▼ −0.47% +0.77% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 9, 2026